ASSOCIATE PROFESSOR, INFECTIOUS DISEASE, School OF MEDICINE, Global Health, Rollins School of Public Health
BACKGROUND
Dr. Rebolledo was born and raised in Mexico City where she received her MD from the Universidad La Salle in Mexico. She completed residency in Internal Medicine, fellowships in Infectious Diseases and Medical Microbiology at Emory University, as well as Master of Science in Clinical Research.Dr. Rebolledo is an associate professor with dual appointments in the School of Medicine (Department of Medicine, Division of Infectious Disease) and the School of Public Health (Department of Global Health). Her research interests center around vaccine-preventable diseases and ensuring the availability of infectious disease diagnostics for resource-limited populations. Dr. Rebolledo is invested in optimizing representation of Latinx populations in vaccine and therapeutic clinical trials and overcoming the systemic barriers to healthcare access for these communities
PROFESSIONAL HIGHLIGHTS
- Co-director, Global Health Distinctions Program, J. Willis Hurst Internal Medicine Residency Program, Emory University School of Medicine
- Investigator, Emory Vaccine and Treatment Evaluation Unit (VTEU) at the Hope Clinic of the Emory Vaccine Center; Emory University School of Medicine
- Associate Professor of Global Health, Hubert Department of Global Health, Emory University
- Associate Professor of Medicine, Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine
- Co-Chair, Latinx Faculty Affinity Group, Emory University School of Medicine
- Co-Chair, Malaria and Tropical Diseases Expert Working Group, Infectious Diseases Clinical Research Consortium
- Mentor, Training Programs in Epidemiology and Public Health Interventions Network (TEPHINET), The Task Force for Global Health
- Member, IDSA Public Health Committee
AREAS OF INTEREST
- Vaccine and therapeutic clinical trials for infectious diseases
- Immunology of vaccine responses in pathogens of public health importance across the globe
- Inclusion of underrepresented populations in clinical trials
- Achieving appropriate use of microbiologic tests (i.e., diagnostic stewardship) through intervention-based medical education
PUBLICATIONS